<DOC>
	<DOCNO>NCT01338805</DOCNO>
	<brief_summary>This long-term extension study ass safety , tolerability efficacy BGG492 adjunctive treatment patient partial onset seizure .</brief_summary>
	<brief_title>Phase II BGG492 Capsule Extension Partial Epilepsy</brief_title>
	<detailed_description />
	<mesh_term>Seizures</mesh_term>
	<criteria>Completed study CBGG492A2207 , cooperate study procedure experience persistent tolerability issue Outpatients ≥ 45 kg ( 99 lb ) weight Patient would like continue BGG492 treatment investigator believe reasonable benefit longterm administration BGG492 may expect Treated stable dose one maximum three license Antiepileptic drug ( AEDs ) know take medication ( ) direct Will make available study period able record seizures report adverse event caregiver record report event Provided write informed consent extension assessment perform Status epilepticus seizure cluster occur study CBGG492A2207 period end study double blind study start study CBGG492A2212 patient experience treatment gap Have treat : Felbamate , unless treatment continuous ≥ 2 year Vigabatrin 26 week prior first dose openlabel medication extension study Monoamine oxidase ( MAO ) inhibitor , tricyclicantidepressants narcotic analgesic LDopa formulation Use concomitant medication potential inhibitor Organic aniontransporting polypeptide ( OATP ) transporters No physical examination change suggestive progressive neurological change Study CBGG492A2207 Used another investigational drug ( BGG492 ) either time enrollment extension study within 5 halflives prior enrollment extension study History hypersensitivity study drug drug similar chemical class ( e.g . sulfonamide ) multiple drug allergy one severe drug reaction Antiepileptic drug ( AEDs ) , include dermatological reaction Pregnant nursing ( lactate ) woman Other protocoldefined inclusion/exclusion criterion may apply</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>66 Years</maximum_age>
	<verification_date>March 2016</verification_date>
	<keyword>Partial onset seizure</keyword>
	<keyword>seizure frequency</keyword>
	<keyword>nervous system disease</keyword>
	<keyword>central nervous system disease</keyword>
	<keyword>CNS</keyword>
	<keyword>brain disease</keyword>
	<keyword>neurologic manifestation</keyword>
	<keyword>adjunctive treatment</keyword>
	<keyword>AEDs</keyword>
	<keyword>antiepileptic drug</keyword>
</DOC>